Effects of 4-HPR on Breast Cancer Cell Lines
Author Information
Author(s): RE Favoni, A de Cupis, S Bruno, D Yee, A Ferrera, P Piranil, A Costa, A Decensi
Primary Institution: National Institute for Cancer Research
Hypothesis
Does N-(4-hydroxyphenyl)-retinamide (4-HPR) inhibit the growth of breast cancer cell lines by modulating the insulin-like growth factor I (IGF-I) system?
Conclusion
4-HPR significantly inhibits the growth of both ER+ and ER- breast cancer cell lines by down-regulating the IGF-I system.
Supporting Evidence
- 4-HPR treatment led to a significant reduction in IGF-I-like protein concentration in both MCF-7 and MDA-MB231 cell lines.
- Induction of apoptosis was more evident in MCF-7 cells compared to MDA-MB231 cells.
- 4-HPR inhibited IGF-I stimulated cell proliferation in MCF-7 cells.
- 4-HPR reduced the levels of IGF-binding proteins in both cancer cell lines.
Takeaway
A substance called 4-HPR can help stop breast cancer cells from growing by messing with a growth system in the cells.
Methodology
The study involved treating breast cancer cell lines with varying concentrations of 4-HPR and measuring cell growth and IGF-I system modulation.
Limitations
The study was conducted in vitro, and results may not fully translate to in vivo conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website